Detalhe da pesquisa
1.
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Int J Mol Sci;
23(15)2022 Jul 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35955449
2.
A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
Europace;
21(9): 1410-1421, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31106349
3.
Novel insights in the pathomechanism of Brugada syndrome and fever-related type 1 ECG changes in a preclinical study using human-induced pluripotent stem cell-derived cardiomyocytes.
Clin Transl Med;
13(3): e1130, 2023 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36881552
4.
Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Front Cell Dev Biol;
7: 261, 2019.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31737628
5.
Deciphering the pathogenic role of a variant with uncertain significance for short QT and Brugada syndromes using gene-edited human-induced pluripotent stem cell-derived cardiomyocytes and preclinical drug screening.
Clin Transl Med;
11(12): e646, 2021 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34954893